ERBB2 and cancer: In addition, we demonstrated that lack of this cytokine caused alterations in immune populations and in vaccine efficacy, showing that IL-15 and/or its regulated populations are necessary for long-term cancer immunoprevention induced by an IL-12-adjuvanted allogeneic HER2/neu-expressing cell vaccine.